HTS Flow Cytometry, Small-Molecule Discovery, and the NIH Molecular Libraries Initiative

Flow Cytometry in Drug Discovery and Development

Volumn , Issue , 2010, Pages 71-97

  Sklar, Larry A ^a   Edwards, Bruce S ^a  

^a UNIVERSITY OF NEW MEXICO   (United States)

Author keywords

Flow cytometry in drug development process HTS flow cytometry, small molecule discovery and NIH molecular libraries initiative; HyperCyt integration, achievement by all commercial flow cytometry systems; UNMCMD flow cytometry in New Mexico interplay, technology at Los Alamos National Laboratory and National Flow Cytometry Resource and Biology at UNM

Indexed keywords

EID: 84860013857     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470910085.ch4     Document Type: Chapter

References (62)

1. Human Genome Project Pilot Phase: http://www.genome.gov/10000511.
2. Human Genome Project Production Phase: http://www.genome.gov/10001792.
3. Collins, FS. The language of god. A Scientist Presents Evidence for Belief, Simon and Schuster, 2006, p. 320.
4. Bioengineering Research Partnerships: http://grants.nih.gov/grants/guide/pa-files/PAR-04-023.html.
5. Bioengineering Research Grants: http://grants.nih.gov/grants/guide/pa-files/PA-02-011. html.
6. Exploratory Bioengineering Research Grants: http://grants.nih.gov/grants/guide/pa-files/ PA-03-058.html.
7. Bioengineering Consortium Symposia: http://www.becon.nih.gov/becon_symposia.htm.
8. NIH Common Fund-about the NIH Roadmap: http://nihroadmap.nih.gov/aboutroadmap. asp.
9. Molecular Libraries Program: http://mli.nih.gov/mli/mlpcn/.
10. PubChem. http://pubchem.ncbi.nlm.nih.gov/.
11. Couzin J. NIH dives into drug discovery. Science 2003;302(5643):218-222.
12. Oprea TI, Bologa CG, Boyer S, Curpan RF, Glen RC, Hopkins AL, Lipinski CA, Marshall GR, Martin YC, Ostopovici-Halip L, Rishton G, Ursu O,Vaz RJ,Waller CL,Waldmann H, Sklar LA. A crowdsourcing evaluation of the NIH chemical probes. Nat. Chem. Biol. 2009;5:441-447.
13. Academic Screening Center Directory: http://www.sbsonline.org/i4a/member_directory/feResultsListing.cfm?directory_id=7&viewAll=1.
14. Solicitation of Assays for High Throughput Screening (HTS) in the Molecular Libraries Probe Production Centers Network (MLPCN) (R03) PAR 09 129.
15. Assay Development for High Throughput Molecular Screening (R21): http://grants.nih. gov/grants/guide/pa-files/par-10-182.html.
16. Fast Track Notice of Opportunity for R01: http://grants.nih.gov/grants/guide/notice-files/NOT-RM-09-011.html.
17. Fast Track Notice of Opportunity for R21: http://grants.nih.gov/grants/guide/notice-files/NOT-RM-09-008.html.
18. Molecular Libraries Fund Opportunities: http://mli.nih.gov/mli/funding-opportunities/.
19. National Center for Biotechnology Information: http://www.ncbi.nlm.nih.gov/.
20. Molecular Libraries probes: http://mli.nih.gov/mli/mlp-probes/.
21. Molecular Libraries funded research: http://nihroadmap.nih.gov/molecularlibraries/fundedresearch.asp.
22. NIH Reporter database: http://projectreporter.nih.gov/reporter.cfm.
23. Molecular Libraries home: http://mli.nih.gov/mli/mlpcn/.
24. NExT Program: http://ncitranslates.nci.nih.gov/docs/presentations/Doroshow11052009_508.pdf.
25. NCI Chemical Biology Consortium: http://dctd.cancer.gov/CurrentResearch/ChemicalBioConsortium.htm.
26. NIH Director's Opportunity for Research in Five Thematic Areas (RFA OD-10-005): http://www.nidcd.nih.gov/funding/ARRARC4.htm.
27. European Strategy Forum on Research Infrastructure: http://cordis.europa.eu/esfri/. and European Infrastructure for Open Screening Platforms for Chemical Biology: http://www.eu-openscreen.de/.
28. European Membrane Protein Network: http://www.mepnet.org/.
29. Sklar LA, Carter MB, Edwards BS. Flow cytometry in drug discovery, receptor pharmacology, and high throughput screening. Curr. Opin. Pharmacol. 2007;7:527-534.
30. Edwards BS,Young SM, Saunders MJ, Bologa CG, Oprea TI,Ye RD, Prossnitz ER, Graves SW, Sklar LA. High throughput flow cytometry for drug discovery. Expert Opin. Drug Discov. 2007;2:685-696.
31. Edwards BE, Kuckuck F, Sklar LA. Plug-flow flow cytometry: an automated coupling device for rapid sequential flowcytometric sample analysis. Cytometry 1999;37:156-159.
32. Kuckuck F, Edwards BS, Sklar LA. High throughput flow cytometry. Cytometry 2001;44:83-90.
33. Intellicyt: http://www.intellicyt.com/.
34. Viviabiotecch: http://www.viviabiotech.com/equipo.html.
35. RigelAutomation ofHyperCyt: http://www.intellicyt.com/download/RigelSBSAutomationPoster.pdf.
36. Intellicyt-Beckman Coulter Agreement: http://www.beckmancoulter.com/HR/PressRoom/oc_pressReleases_detail.asp?Key=8962.
37. Edwards BS, Young SM, Oprea TI, Bologa CG, Prossnitz ER, Sklar LA. Biomolecular screening of formylpeptide receptor ligands with a sensitive, quantitative, high-throughput flow cytometry platform. Nat. Protoc. 2006;1:59-66.
38. Strouse JJ,Young, SM, Mitchell HD,Ye RD, Prossnitz ER, Sklar LA, Edwards BS.Anovel fluorescent cross-reactive formylpeptide. Cytometry 2009;75(3):264-270.
39. Young SM, Bologa CM, Fara D, Bryant BK, Strouse JJ, Arterburn JB, Ye RD, Oprea TI, Prossnitz ER, Sklar LA, Edwards BS. Duplex high-throughput flow cytometry screen identifies two novel formylpeptide receptor family probes. Cytometry A 2009;75:253-263.
40. Deffenbaugh AE, Scaglione KM, Zhang L, Moore JM, Buranda T, Sklar LA, Skowyra D. Release of ubiquitin-charged Cdc34-S-Ub from the RING domain is essential for ubiquitination of the SCF(Cdc4)-bound substrate Sic1. Cell 2003;114:611-622.
41. Babbitt, SE, Kiss, A, Deffenbaugh, AE, Erdjument-Bromage, H, Tempst, P, Bailly, E, Buranda, T, Sklar, LA, Baumler, J, Gogol, E, Skowyra, D. ATP hydrolysis-dependent disassembly of the 26S proteasome is part of the catalytic cycle. Cell 2005;121: 553-565.
42. Revankar C, Cimino D, Sklar LA, Arterburn J, Prossnitz, ER. An intracellular 7-transmembrane G-protein coupled estrogen receptor mediates rapid cell signaling. Science 2005;307:1625-1630.
43. Bologa CG, Revankar CM, Young SM, Edwards BS, Arterburn JB, Kiselyov AS, Parker MA, Tkachenko SE, Savchuck NP, Sklar LA, Oprea TI, Prossnitz ER. Virtual and biomolecular screening converge on a selective agonist for GPR30. Nat. Chem. Biol. 2006;2:207-212.
44. Dennis MK, Burai R, Ramesh C, Petrie WK, Alcon SN, Nayak TK, Bologa CG, Leitao A, Brailoiu E, Deliu E, Dun NJ, Sklar LA, Hathaway HJ, Arterburn JB, Oprea TI, Prossnitz ER. In vivo effects of a GPR30 antagonist. Nat. Chem. Biol. 2009;5:421-427.
45. Njus BH, Chigaev A,Waller A, Wlodek D, Ostopovici-Halip L, Ursu O,WangW, Oprea TI, Bologa CG, Sklar LA. Conformational mAb as a tool for integrin ligand discovery. Assay Drug Dev. Technol. 2009;5:507-515.
46. Chigaev A, Waller A, Amit O, Halip L, Bologa CG, Sklar LA. Real-time analysis of conformation-sensitive antibody binding provides new insights into integrin conformational regulation. J. Biol. Chem. 2009;284(21):14337-14346.
47. Dennis MK, Bowles HJC, MacKenzie DA, Burchiel SW, Edwards BS, Sklar LA, Prossnitz ER, Thompson TA. A multifunctional androgen receptor screening (MARS) assay for the identification of compounds that modulate androgen receptor activity using the high-throughput HyperCyt® flow cytometry system. Cytometry 2008;73 (5):390-399.
48. Haynes MK, Strouse JJ,Waller A, Leitao A, Curpan RF, Bologa C, Oprea TI, Prossnitz ER, Edwards BS, Sklar LA, Thompson TA. Detection of intracellular granularity induction in prostate cancer cell lines by small molecules using the HyperCyt® high throughput flow cytometry system. J. Biomol. Screen. 2009;14:596-609.
49. Tessema M, Simons PC, Cimino DF, Sanchez L,Waller A, Posner RG,Wandinger-Ness A, Prossnitz ER, Sklar LA. Glutathione-S-transferase-green fluorescent protein fusion protein reveals slow dissociation from high site density beads and measures free GSH. Cytometry A 2006;69:326-334.
50. Schwartz SL, Tessema M, Pylypenko O, Rak A, Simons P, Surviladze Z, Sklar LA, Wandinger-Ness A. Flow cytometry for real-time measurement of guanine nucleotide binding and exchange by Ras-like GTPases. Anal. Biochem. 2008;381:258-266.
51. Surviladze Z, Waller A, Wu Y, Romero E, Edwards BS, Wandinger-Ness A, Sklar LA. Identification of a small GTPase inhibitor using a high-throughput flow cytometry beadbased multiplex assay. J. Biomol. Screen. 2010;15(1):10-20.
52. Roman DL, Ota S, Neubig RR. Polyplexed flow cytometry protein interaction assay: a novel high-throughput screening paradigm for RGS protein inhibitors. J. Biomol. Screen. 2009;14(6):610-619.
53. Blazer LL, Roman DL, Muxlow MR, Neubig RR. Use of flow cytometric methods to quantify protein-protein interactions. Curr. Protoc. Cytom. 2010;51:13.11.1-13.11.15
54. Winter SS, Lovato DM, Khawaja HM, Edwards BS, Ivnitski-Steele ID, Young SM, Oprea TI, Sklar LA, Larson RS. High throughput screening for daunorubicin-mediated drug resistance identifies mometasone furoate as a novel ABCB1 reversal agent. J. Biomol. Screen. 2008;13:185-193.
55. Ivnitski-Steele I, Larson RS, Lovato DM, Khawaja HM, Winter SS, Oprea TI, Sklar LA, Edwards BS. High-throughput flow cytometry to detect selective inhibitors of ABCB1, ABCC1, and ABCG2 transporters. Assay Drug Dev. Technol. 2008;6(2):263-276.
56. Nakamura K, Zawistowski JS, Hughes MA, Sexton JZ, Yeh LA, Johnson GL, Scott JE. Homogeneous time-resolved fluorescence resonance energy transfer assay for measurement of Phox/Bem1p (PB1) domain heterodimerization. J. Biomol. Screen. 2008;13(5):396-405.
57. Kim K,Wang L, Hwang I. A novel flow cytometric high throughput assay for a systematic study on molecular mechanisms underlying T cell receptor-mediated integrin activation. PLoS One 2009;4(6):e6044.
58. Ivnitski-Steele I, Holmes AR, Lamping E, Monk BC, Cannon RD, Sklar LA. Identification of Nile red as a fluorescent substrate of the Candida albicans ATP-binding cassette transporters Cdr1p and Cdr2p and the major facilitator superfamily transporter Mdr1p. Anal. Biochem. 2009;394(1):87-91.
59. Simons P, Shi M, Foutz T, Lewis J, Buranda T, Lim WK, Neubig R, Garrison J, Prossnitz ER, Sklar LA. Beads coated with epitope tagged G proteins assemble complexes of ligand-receptor-G protein for detection by flow cytometry. Mol. Pharm. 2003;64:1227-1238.
60. Simons PC, Young SM, Gibaja V, Lee W-C, Josiah S, Edwards BS, Sklar LA. Duplex, bead-based, competitive assays for inhibitors of protein kinase. Cytometry 2007;7:451-459.
61. Saunders MJ, Kim H, Woods TA, Nolan JP, Sklar LA, Edwards BS, Graves SW. Microsphere based protease assays and screening application for lethal factor and factor Xa. Cytometry A 2006;69:342-352.
62. Saunders M, Edwards BS, Sklar LA, Graves S.High throughput multiplex flow cytometry screening for botulinum neurotoxin type A light chain protease inhibitors, assays and target development. Assay Drug Dev. Technol. 2010:8, 37-46.